Long Qt Syndrome Type 3
📧 Sign up to get email alerts when something new happens for Long Qt Syndrome Type 3.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-01-12Clinical Trial Update: Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3 [Phase 3]
Phase 3 trial evaluating eleclazine for shortening QT interval, safety, and tolerability in adults with Long QT Syndrome Type 3; study termi…
-
CLINICAL_TRIALS research · 2015-05-14Clinical Trial Update: Worm Study: Modifier Genes in Sudden Cardiac Death [NA]
A worm-model study update investigating modifier genes in sudden cardiac death, associated with Brugada syndrome and Long QT syndrome type 3…
-
CLINICAL_TRIALS research · 2015-03-26Clinical Trial Update: Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine [Phase 2]
Phase 2 clinical trial update assessing long-term prophylaxis with ranolazine for congenital Long QT Syndrome Type 3.